251 related articles for article (PubMed ID: 21577103)
1. Epigenetics and B-cell lymphoma.
Shaknovich R; Melnick A
Curr Opin Hematol; 2011 Jul; 18(4):293-9. PubMed ID: 21577103
[TBL] [Abstract][Full Text] [Related]
2. The many layers of epigenetic dysfunction in B-cell lymphomas.
Jiang Y; Dominguez PM; Melnick AM
Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
[TBL] [Abstract][Full Text] [Related]
3. The new frontier of epigenetic heterogeneity in B-cell neoplasms.
Dominguez PM; Teater M; Shaknovich R
Curr Opin Hematol; 2017 Jul; 24(4):402-408. PubMed ID: 28375986
[TBL] [Abstract][Full Text] [Related]
4. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.
Martín-Subero JI; Kreuz M; Bibikova M; Bentink S; Ammerpohl O; Wickham-Garcia E; Rosolowski M; Richter J; Lopez-Serra L; Ballestar E; Berger H; Agirre X; Bernd HW; Calvanese V; Cogliatti SB; Drexler HG; Fan JB; Fraga MF; Hansmann ML; Hummel M; Klapper W; Korn B; Küppers R; Macleod RA; Möller P; Ott G; Pott C; Prosper F; Rosenwald A; Schwaenen C; Schübeler D; Seifert M; Stürzenhofecker B; Weber M; Wessendorf S; Loeffler M; Trümper L; Stein H; Spang R; Esteller M; Barker D; Hasenclever D; Siebert R;
Blood; 2009 Mar; 113(11):2488-97. PubMed ID: 19075189
[TBL] [Abstract][Full Text] [Related]
5. JMJD3 as an epigenetic regulator in development and disease.
Burchfield JS; Li Q; Wang HY; Wang RF
Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Mechanisms in Leukemias and Lymphomas.
Duy C; Béguelin W; Melnick A
Cold Spring Harb Perspect Med; 2020 Dec; 10(12):. PubMed ID: 32014848
[TBL] [Abstract][Full Text] [Related]
7. The epigenetic basis of diffuse large B-cell lymphoma.
Jiang Y; Melnick A
Semin Hematol; 2015 Apr; 52(2):86-96. PubMed ID: 25805588
[TBL] [Abstract][Full Text] [Related]
8. Short-Circuiting Gene Regulatory Networks: Origins of B Cell Lymphoma.
Koues OI; Oltz EM; Payton JE
Trends Genet; 2015 Dec; 31(12):720-731. PubMed ID: 26604030
[TBL] [Abstract][Full Text] [Related]
9. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
10. Targeting histone deacetyalses in the treatment of B- and T-cell malignancies.
Zain J; O'Connor OA
Invest New Drugs; 2010 Dec; 28 Suppl 1(Suppl 1):S58-78. PubMed ID: 21132350
[TBL] [Abstract][Full Text] [Related]
11. Chromatin-Remodeled State in Lymphoma.
Liu Y; Gonzalez Y; Amengual JE
Curr Hematol Malig Rep; 2019 Oct; 14(5):439-450. PubMed ID: 31489524
[TBL] [Abstract][Full Text] [Related]
12. An epigenetic view of B-cell disorders.
Alberghini F; Petrocelli V; Rahmat M; Casola S
Immunol Cell Biol; 2015 Mar; 93(3):253-60. PubMed ID: 25601271
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.
Rossi D; Capello D; Gloghini A; Franceschetti S; Paulli M; Bhatia K; Saglio G; Vitolo U; Pileri SA; Esteller M; Carbone A; Gaidano G
Haematologica; 2004 Feb; 89(2):154-64. PubMed ID: 15003890
[TBL] [Abstract][Full Text] [Related]
14. Clinical advances in epigenetic therapies for lymphoma.
Rosenthal AC; Munoz JL; Villasboas JC
Clin Epigenetics; 2023 Mar; 15(1):39. PubMed ID: 36871057
[TBL] [Abstract][Full Text] [Related]
15. Cooperative epigenetic modulation by cancer amplicon genes.
Rui L; Emre NC; Kruhlak MJ; Chung HJ; Steidl C; Slack G; Wright GW; Lenz G; Ngo VN; Shaffer AL; Xu W; Zhao H; Yang Y; Lamy L; Davis RE; Xiao W; Powell J; Maloney D; Thomas CJ; Möller P; Rosenwald A; Ott G; Muller-Hermelink HK; Savage K; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Weisenburger DD; Chan WC; Gascoyne RD; Levens D; Staudt LM
Cancer Cell; 2010 Dec; 18(6):590-605. PubMed ID: 21156283
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies.
Serganova I; Chakraborty S; Yamshon S; Isshiki Y; Bucktrout R; Melnick A; Béguelin W; Zappasodi R
Front Cell Dev Biol; 2021; 9():805195. PubMed ID: 35071240
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of lymphomas in the era of epigenetics.
Chebly A; Chouery E; Ropio J; Kourie HR; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Blood Rev; 2021 Jul; 48():100782. PubMed ID: 33229141
[TBL] [Abstract][Full Text] [Related]
18. Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
Matsuda I; Imai Y; Hirota S
J Clin Exp Hematop; 2014; 54(1):67-73. PubMed ID: 24942948
[TBL] [Abstract][Full Text] [Related]
19. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic Characterization of Lymphoid Neoplasms.
Duran-Ferrer M; Martín-Subero JI
Annu Rev Pathol; 2024 Jan; 19():371-396. PubMed ID: 37832942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
